You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cediranib

Showing 26 - 50 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Trial in Worldwide (carboplatin, cediranib maleate, paclitaxel)

Completed
  • Lung Cancer
  • Buenos Aires, Argentina
  • +19 more
Apr 2, 2020

Ovarian Tumors Trial in Italy (Paclitaxel, Cediranib, Olaparib)

Unknown status
  • Ovarian Neoplasms
  • Brescia, BS, Italy
  • +5 more
May 13, 2019

Colorectal Cancer, Lung Cancer Trial in Ottawa, Toronto, Montreal (cediranib maleate, cisplatin, fluorouracil)

Completed
  • Colorectal Cancer
  • Lung Cancer
  • cediranib maleate
  • +5 more
  • Ottawa, Ontario, Canada
  • +2 more
Apr 6, 2020

Alveolar Soft-part Sarcoma Trial in Australia, Spain, United Kingdom (Cediranib, Placebo)

Unknown status
  • Alveolar Soft-part Sarcoma
  • Cediranib
  • Placebo
  • Brisbane, Australia
  • +10 more
Jan 22, 2019

Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Uterine Carcinosarcoma
  • New York, New York
  • +2 more
Apr 4, 2022

Hormone Refractory Prostate Cancer, Recurrent Prostate Cancer Trial in Canada, United States (cediranib maleate, dasatinib)

Completed
Has Results
  • Hormone Refractory Prostate Cancer
  • Recurrent Prostate Cancer
  • Peoria, Illinois
  • +7 more
Jul 9, 2018

Glioblastoma Trial in Montpellier (supportive care)

Completed
  • Glioblastoma
  • supportive care
  • Montpellier, France
    ICM Val d'Aurelle
Mar 11, 2022

Ovarian Cancer Trial in Toronto (Olaparib, Cediranib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jun 11, 2018

Adenocarcinoma of the Prostate, Stage IV Prostate Cancer Trial in Detroit, Houston, Madison (cediranib maleate, docetaxel,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • Stage IV Prostate Cancer
  • cediranib maleate
  • +3 more
  • Detroit, Michigan
  • +3 more
Jul 13, 2018

Ovarian Carcinoma Trial in France (Tamoxifen, Regorafenib)

Active, not recruiting
  • Ovarian Carcinoma
  • Angers, France
  • +25 more
Oct 6, 2021

Prostate Cancer Trial run by the NCI (Magnetic Resonance Imaging (DCE-MRI), AZD2171, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • Magnetic Resonance Imaging (DCE-MRI)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 4, 2018

Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma,

Completed
Has Results
  • Acral Lentiginous Malignant Melanoma
  • +10 more
  • cediranib maleate
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 27, 2018

Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer Trial in Italy (Carboplatin, Paclitaxel,

Recruiting
  • Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
  • Legnago, Italy
  • +6 more
Aug 24, 2021

Advanced Biliary Tract Cancer Trial in Beijing (Toripalimab plus Lenvatinib)

Unknown status
  • Advanced Biliary Tract Cancer
  • Toripalimab plus Lenvatinib
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Nov 30, 2020

Recurrent NSCLC Trial in Baltimore, Detroit (cediranib maleate, pemetrexed disodium)

Completed
Has Results
  • Recurrent Non-small Cell Lung Cancer
  • cediranib maleate
  • pemetrexed disodium
  • Baltimore, Maryland
  • +1 more
Mar 15, 2018

Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma Trial in San Antonio (cediranib

Completed
Has Results
  • Advanced Malignant Mesothelioma
  • +3 more
  • cediranib maleate
  • laboratory biomarker analysis
  • San Antonio, Texas
    Southwest Oncology Group
Dec 27, 2017

Recurrent Endometrial Cancer Trial (Pembrolizumab, Axitinib)

Withdrawn
  • Recurrent Endometrial Cancer
  • (no location specified)
Nov 4, 2020

Glioblastoma Trial in United Kingdom (cediranib maleate, gefitinib, Placebo)

Terminated
Has Results
  • Glioblastoma
  • cediranib maleate
  • +2 more
  • London, England, United Kingdom
  • +9 more
May 2, 2017

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in Boston (drug, procedure, radiation, other)

Completed
  • Adult Giant Cell Glioblastoma
  • +2 more
  • Cediranib Maleate
  • +9 more
  • Boston, Massachusetts
  • +2 more
Sep 15, 2017

Renal Cell Carcinoma Trial in Netherlands, United Kingdom (Cediranib, Cediranib Placebo)

Completed
Has Results
  • Renal Cell Carcinoma
  • Cediranib
  • Cediranib Placebo
  • Groningen, Netherlands
  • +7 more
Dec 8, 2016

Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct

Terminated
Has Results
  • Adult Primary Cholangiocellular Carcinoma
  • +10 more
  • cediranib maleate
  • +3 more
  • Cleveland, Ohio
  • +6 more
Feb 10, 2017

Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma Trial in United States (Cediranib Maleate)

Terminated
Has Results
  • Neurofibromatosis Type 1
  • +2 more
  • Cediranib Maleate
  • Birmingham, Alabama
  • +8 more
Jul 21, 2017

Recurrent Glioblastoma Trial in Worldwide (Cediranib, Lomustine Chemotherapy, Placebo Cediranib)

Completed
Has Results
  • Recurrent Glioblastoma
  • Cediranib
  • +2 more
  • Birmingham, Alabama
  • +61 more
Nov 7, 2016

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Completed
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +10 more
  • cediranib maleate
  • laboratory biomarker analysis
  • Washington, District of Columbia
  • +4 more
Dec 28, 2016

Metastatic Alveolar Soft Part Sarcoma Trial in Seoul (Pazopanib)

Terminated
  • Metastatic Alveolar Soft Part Sarcoma
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 3, 2017